STELLA PHARMA
NEWS
July 30th, 2025
Paper published: Poly(vinyl alcohol) Enhancing Therapeutic Effects of 4-L-Boronophenylalanine on Thoracic Tumors in Neutron Capture Therapy
The paper published in the International Journal of Pharmaceutics describes the……
July 28th, 2025
Achievement of Primary Endpoints in Phase II Clinical Trial Targeting Angiosarcoma in Japan —Detailed Trial Results to Be Presented at ESMO Congress 2025—
We are pleased to announce that the Phase II clinical trial for angiosarc……
June 4th, 2025
We participated in the 2025 Annual Meeting of the American Society of Clinical Oncology (ASCO)
We, Stella Pharma, participated in the 2025 Annual Meeting of the American Soci……
May 23rd, 2025
Statistically Significant Difference in Results for Primary Endpoint of Clinical Trial for Recurrent High-Grade Meningioma – Presentation at the 2025 Annual Meeting of the American Society of Clinical Oncology (ASCO)
Stella Pharma is pleased to announce the results of the Phase II investigator-i……
